• Non ci sono risultati.

Riparazione tissutale

N/A
N/A
Protected

Academic year: 2021

Condividi "Riparazione tissutale"

Copied!
56
0
0

Testo completo

(1)

Novità nella riparazione

tessutale

tessutale

M R lli

Marco Romanelli

Sezione di Riparazione Tessutale Cutanea Clinica Dermatologica

Università di Pisa Università di Pisa

(2)
(3)

Lesioni acute e croniche Lesioni acute e croniche

(4)
(5)

Ch i d h li

Chronic wound healing

Clinical Evidence Improve l Fluctuate Static Static Deteriorate K. Harding 2004

(6)

The Wound Healing Market is Becoming The Wound Healing Market is Becoming

Increasingly Technology Driven Increasingly Technology Driven

Improved

Improved ACTIVE

Increasingly Technology Driven Increasingly Technology Driven

70’s 70’s 80’s80’s 90’s90’s ‘00‘00 ‘05‘05 Improved Improved Outcomes Outcomes ENVIRONMENT ACTIVE ACTIVE HEALING • Growth factors GF/D i bi ti

MOIST WOUND HEALING

• Hydropolymers • GF/Device combinations • Pharmaceuticals • Tissue Engineering PASSIVE TRADITIONAL • Hydropolymers • Hydrocolloids • Collagen dressings • Gels • Gauze • Sponges

• Saline wet gauze

Time

70 + Years - First Wave 15+ Years - Second Wave Third Wave

(7)

W

d C

Wound Care:

ambulatoriale

o

o

ospedalizzazione

ospedalizzazione

(8)

PROTEIN PROTEIN HUMAN

(9)

Top 5

Wound Wound Advances

(10)

Wound Management

Valutazione morfologica

Valutazione morfologica

-- Adeguata

Adeguata

90%

90%

Valutazione morfologica

Valutazione morfologica

Adeguata

Adeguata

90%

90%

-- Incompleta

Incompleta 10%

10%

Ancillary Tests

Ancillary Tests

Ancillary Tests

Ancillary Tests

(11)

Valutazione paziente

Valutazione paziente

Valutazione paziente

Valutazione paziente

IHC

(12)
(13)

A J Cli P th l 2004 121 528

A J Cli P th l 2004 121 528 536536 Am J Clin Pathol 2004; 121: 528

(14)
(15)

Histology Histology Histology Histology Biopsy Biopsy Fresh Tissue Fresh Tissue Biopsy Biopsy Fresh Tissue Fresh Tissue sto ogy sto ogy sto ogy sto ogy Fresh Tissue Fresh Tissue Fresh Tissue Fresh Tissue

RTP

RTP

RTP

RTP

AncillaryAncillaryAncillaryAncillaryTestsTestsTestsTestsTestsTestsTestsTests

Formalin Formalin Fixation Fixation Formalin Formalin Fixation

Fixation Molecular Molecular Molecular Molecular StudiesStudiesStudiesStudies Fixation

Fixation Fixation

(16)

HC/IHC/ISH Flowcytometry Microdissection Genomics Proteomics Proteomics

(17)

Tissue-Based “

omics

Impatto sulla diagnosi e

g

gestione delle malattie

(18)

?

?

?

?

(19)

ARANZ Medical

ARANZ Medical Silhouette

Solution for wound imaging,Solution for wound imaging,

Silhouette

measurement and documentation

• Measures area, depth, volume • Allows structure entry of wound

assessment notes • EfficientEfficient • Repeatable • Portable • Easy to use • Non-contact

• Data accessible over the web • Data accessible over the web

• Integrates with Health Information Systems

SilhouetteMobile in clinical use

(20)

ARANZ Medical

ARANZ Medical SilhouetteMobileSilhouetteMobile

Silh tt C f SilhouetteCamera for image acquisition

Off-the-shelf PDA (personal computing device)

i l

Silhouette application software for:

- image capture,

- analysisanalysis (area depth & volume)(area, depth & volume)

- report generation - email / fax / backup

(21)

VivaScope

VivaScope®® 3000 Confocal Microscope3000 Confocal Microscope

The VivaScope® 3000 is a hand-held laser confocal microscope capable of video-rate imaging of living

tissue at the cellular level. This device potentially can be used as an in vivo or intra-operative device to examine the morphological features and dynamic processes of tissue in real time. The non-invasive “optical biopsy” generated by the VivaScope provides medical practitioners with information that can be used as an adjunct to histology.

•Provides real time, video rate sample assessment

• Images cells in vivo for diagnostic and therapeutic research • Images cells in vivo for diagnostic and therapeutic research

• Allows for observation of a site over time to study progression of disease • Assists in pre-operative and intra-operative margin evaluation

(22)

Composite map or VivaBlock measuring 2 x 1.5 mm taken at the top of the

( )

reticular dermis shows dense scar tissue (blue arrows) and elongated capillaries (red arrows) adjacent to a normal papillary dermis (green arrows).

(23)

Top 5

Wound Wound advances Medicazioni Avanzate Diagnostica

(24)

Medicazioni Avanzate Medicazioni Avanzate

(25)

Terapia delle infezioni Terapia delle infezioni

Opzioni Opzioni • Debridement o farmaci • Antisettici o antibiotici T i i i t i i • Topici o sistemici

• Breve o lunga durataBreve o lunga durata

• Prevenzione o trattamento • Tradizionale o nuova

(26)

Terapia delle infezioni

Terapia delle infezioni

Tradizionale Tradizionale Miele - Cooper 1999p Yoghurt -Acido acetico -Potassio Permanganato

-Larve - Church Thomas

(27)

T

i d ll i f i

i

Terapia delle infezioni

Avanzata

VAC® - Argenta, Banwell

Avanzata

Citochine - Edmonds

Normotermia - Melling 2002

MMP inhibitori - Cullen Veves

(28)

Ulcera da pressione grado III

con infezione superficiale

(29)

Dopo terapia con

(30)

b

l

dopo

3 settimane

(31)

ulcera

ulcera

ischemica

ischemica

(32)

Medicazione b di a base di Collagene Collagene Equinoq

(33)
(34)
(35)

Top 5

Wound Wound Advances Dispositivi Meccanici Medicazioni Avanzate Diagnostica

(36)

V A C ® system

V.A.C.® system

(37)

Indicazioni

Indicazioni

Ulcere cronicheUlcere croniche • Ulcere diabetiche • Ulcere da pressione • Ulcere venose

Ferite acute e traumatiche

Ferite subacute • Ferite subacute • Deiscenze chirurgicheInnesti a rete Lembi di rotzioneLembi di rotzione

(38)

Carica batterica

Superficie

Profondità Profondità

(39)

Terapia Fotodinamica (PDT) in

Terapia Fotodinamica (PDT) in

wound healing

wou d ea

g

(40)

Killi

f

t

i

bi l

Killing of cutaneous microbial

species by photodynamic therapy

p

y p

y

py

Zeina B. et al. Br J Dermatol 2001; 144: 274-278

Cytotoxic effects of antimicrobial

Cytotoxic effects of antimicrobial

photodynamic therapy on keratinocytes

in vitro

Zeina B et al Br J Dermatol 2002; 146: 568 573 Zeina B. et al. Br J Dermatol 2002; 146: 568-573

(41)

Prolonged skin allograft survival after g g photodynamic therapy (PDT)

associated with modification of donor associated with modification of donor

skin antigenicity Modestus O K et al Modestus O.K. et al Transplantation 1997; 63: 810 -817 817

(42)

Top 5

Wound Wound Advances Farmaci Dispositivi Meccanici Medicazioni Avanzate Diagnostica

(43)

Pyoderma Gangrenosum

Geren S. et al WOUNDS 2003; 15: 49-53

Infliximab 4

Infliximab 4--6 mg/kg6 mg/kg Weeks 0, 2, and 8 then every 6

(44)

Staminali

Top 5

Wound Ingegneria Tessutale Wound Advances Farmaci Dispositivi Meccanici Medicazioni Avanzate Diagnostica

(45)

Tissue Engineering

Tissue Engineering

(46)

Skin grafting and

Skin grafting and

tissue engineering

g

g

• Dermagraft® A li f • Apligraf® • Integra® • Transcyte® • EpicelEpicel®® • TissueTech® All d • Alloderm® • Biobrane®

(47)
(48)

Epidermal equivalents from autologous outer root sheath cells for chronic wounds T. Hunziker et al.

(49)
(50)

Use of autologous bone marrow-derived cells to treat chronic wounds.

Arch Dermatol, April 2003 Arch Dermatol, April 2003

(51)

Fattori di crescita come agenti

Fattori di crescita come agenti

terapeutici

p

• Vantaggi Svantaggi • Azione locale • Effetto selettivo • Costi produzione (ricombinanti) t i • Componenti naturali processo proteine • Effetti sistemici ad alte dosi rip. tessutale • Bassa tossicità alte dosi • Durata Biodisponibilità • Biodisponibilità • Somministrazione

(52)

Two General Strategies in

Two General Strategies in

Using Genes for Repair

g

p

• Gene therapy

• Replacement, reduction, or

compensation for an (inborn) genetic compensation for an (inborn) genetic error

• Easy in the lab, tough in the clinic

• Issues of correct targeting and regulation

• Permanent alteration to correct fatal disease

• Gene medicine

• Short term activation or repression of

• Short term activation or repression of a gene to promote innate repair

• Use of genes and/or cells that act transiently

QuickTime™ and a TIFF (LZW) decompressor are needed to see this picture.

(53)

Gene Medicine for Wound Healing:

g

Strategies

• Naked DNA (plasmid)

• Easy to manufacture, hard to get into cells

• Physical and chemical delivery systemsy y y

• Gene gun: surface-dependent

• Incorporation into gels, films, biomaterials, lipsomes, nanoparticles

Fast inefficient inexpensive

• Fast, inefficient, inexpensive

• Viruses - nature’s gene delivery systems • Adenovirus efficient transient

• Adenovirus - efficient, transient

• Retrovirus

-• permanent introduction of genes

• Useful for genetic engineering of tissue g g g engineering products

• Can be used in conjunction with controllable

genes

• Topical activation

• Systemic activation

(54)

Mouse Transfection with Luciferase by Gene Gun/Particle by Gene Gun/Particle Bombardment/ Biolistic T f ti Transfection

• Gene gun loaded

with luc expression p vector

• Introduced intoIntroduced into epidermis at two pressures pressures • Visualized with topical luciferin in topical luciferin in DMSO @ 2d

(55)
(56)

W

d C

Wound Care:

ambulatoriale

o

o

ospedalizzazione

ospedalizzazione

Riferimenti

Documenti correlati

Alcuni tipi cellulari, come cheratinociti, fibroblasti, condrociti, cellule endoteliali, cellule muscolari lisce, sono in grado di proliferare rapidamente e proprio per questo

5.2 First experimental results: Development of a model of hepatic culture that allows creation of an in vitro engineered three dimensional (3D)

The power supplies that are used in an ES setup can use direct current (DC) or alternating current (AC), even if DC is more commonly used than AC. Generally, a

In parallel, and to assess the clinical and diagnostic value of the data accrued in the experimental model, studies were conducted in a series of human breast cancers, both in

Partecipano Laura Dolcetti, Roma - Ivano Migliorini, Roma - Massimiliano Pomponi, Roma - Oreste Sidoli, Parma - Amanda Zanchi, Bergamo. Ore 13.00

Attraverso questa nuova strumentazione i ricercatori sono riusciti a ricavare la curva che descrive la forza contrattile di fibroblasti impiantati all’interno di una matrice

Fibroblast growth factor (FGF) 18 signals through FGF receptor 3 to promote chondrogenesis. De Angelis,A.A., Capitani,D., and Crescenzi,V. Synthesis and C-13 CP-MAS

If a tarsal plate suture is used then additional skin sutures can be removed early (1 week), but if gray line and skin sutures are used without a cardinal tarsal su- ture, then